1-4 of 4
Meritxell Alberich Jordà
Close
Sort by
Journal Articles

Identification of Sox4 As Key Oncogene in Leukemias with Mutated or Silenced C/EBPα

Hong Zhang, PhD, Min Ye, PhD, Meritxell Alberich-Jordà, PhD, Giovanni Amabile, PhD, Philipp B. Staber, M.D., Peter J. M. Valk, PhD, Ruud Delwel, PhD, Véronique Lefebvre, PhD, Constanze Bonifer, PhD, Daniel G. Tenen, MD
Journal: Blood
Blood (2012) 120 (21): 114.
https://doi.org/10.1182/blood.V120.21.114.114
Published: 2012
Journal Articles

The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner

Meritxell Alberich Jordà, Nazik Rayman, Marjolein Tas, Sandra E. Verbakel, Natalia Battista, Kirsten van Lom, Bob Löwenberg, Mauro Maccarrone, Ruud Delwel
Journal: Blood
Blood (2004) 104 (2): 526–534.
https://doi.org/10.1182/blood-2003-12-4357
Published: 2004
Journal Articles

The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation

Meritxell Alberich Jordà, Bob Löwenberg, Ruud Delwel
Journal: Blood
Blood (2003) 101 (4): 1336–1343.
https://doi.org/10.1182/blood-2002-07-2034
Published: 2003
Journal Articles

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

Meritxell Alberich Jordà, Sandra E. Verbakel, Peter J. M. Valk, Yolanda V. Vankan-Berkhoudt, Mauro Maccarrone, Allessandro Finazzi-Agrò, Bob Löwenberg, Ruud Delwel
Journal: Blood
Blood (2002) 99 (8): 2786–2793.
https://doi.org/10.1182/blood.V99.8.2786
Published: 2002